Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan

NCT05361603 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT05361603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan
Lead sponsor
University Hospital, Limoges
Phase
Observational
Overall status
Recruiting
Start date
May 24, 2017
Completion date
February 14, 2030
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction opiate, addiction, alcohol, hepatitis c, hepatitis c virus infection, response to therapy of, transmission, intravenous drug abuser